Castle Biosciences to Present at the Canaccord Genuity 2017 Medical Technologies & Diagnostics Forum
Friendswood, TX – November 2, 2017 Castle Biosciences, Inc., a provider of molecular diagnostics to improve cancer treatment decisions, today announced that Derek Maetzold, President and CEO will be presenting at Canaccord Genuity’s 2017 Medical Technologies & Diagnostics Forum on Thursday, November 9th, 2017 at 1:30 p.m. ET in New York City. About Castle Biosciences …